Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
RR vs BRBS vs NBTB vs CARE vs FIS
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Information Technology Services
RR vs BRBS vs NBTB vs CARE vs FIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Banks - Regional | Banks - Regional | Banks - Regional | Information Technology Services |
| Market Cap | $467M | $320M | $2.35B | $580M | $24.47B |
| Revenue (TTM) | $5M | $151M | $867M | $255M | $10.89B |
| Net Income (TTM) | $-12M | $11M | $169M | $31M | $382M |
| Gross Margin | 55.8% | 63.5% | 72.1% | 61.7% | 38.1% |
| Operating Margin | -5.2% | 9.1% | 25.3% | 15.7% | 17.5% |
| Forward P/E | — | 31.8x | 10.8x | 4.8x | 7.5x |
| Total Debt | $730K | $179M | $327M | $179M | $4.01B |
| Cash & Equiv. | $194M | $116M | $185M | $105M | $599M |
RR vs BRBS vs NBTB vs CARE vs FIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | May 26 | Return |
|---|---|---|---|
| Richtech Robotics I… (RR) | 100 | 62.8 | -37.2% |
| Blue Ridge Bankshar… (BRBS) | 100 | 129.6 | +29.6% |
| NBT Bancorp Inc. (NBTB) | 100 | 126.9 | +26.9% |
| Carter Bankshares, … (CARE) | 100 | 209.0 | +109.0% |
| Fidelity National I… (FIS) | 100 | 80.6 | -19.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RR vs BRBS vs NBTB vs CARE vs FIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RR ranks third and is worth considering specifically for growth exposure.
- Rev growth 19.0%, EPS growth -8.3%, 3Y rev CAGR -5.9%
- 19.0% revenue growth vs BRBS's -13.4%
BRBS has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 0 yrs, beta 0.54, yield 6.1%
- Beta 0.54, yield 6.1%
- NIM 3.2% vs CARE's 2.7%
- Beta 0.54 vs RR's 4.02
NBTB is the clearest fit if your priority is quality.
- 19.5% margin vs RR's -249.5%
CARE is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 112.9% 10Y total return vs NBTB's 102.2%
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
- +69.0% vs FIS's -35.3%
FIS is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.31 vs NBTB's 1.53
- Lower P/E (7.5x vs 10.8x), PEG 0.31 vs 1.53
- 1.1% ROA vs RR's -3.5%, ROIC 6.0% vs -25.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.0% revenue growth vs BRBS's -13.4% | |
| Value | Lower P/E (7.5x vs 10.8x), PEG 0.31 vs 1.53 | |
| Quality / Margins | 19.5% margin vs RR's -249.5% | |
| Stability / Safety | Beta 0.54 vs RR's 4.02 | |
| Dividends | 6.1% yield, vs NBTB's 3.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs FIS's -35.3% | |
| Efficiency (ROA) | 1.1% ROA vs RR's -3.5%, ROIC 6.0% vs -25.7% |
RR vs BRBS vs NBTB vs CARE vs FIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RR vs BRBS vs NBTB vs CARE vs FIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 1 of 6 categories
CARE leads 1 • RR leads 0 • BRBS leads 0 • FIS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FIS is the larger business by revenue, generating $10.9B annually — 2207.7x RR's $5M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to RR's -2.5%. On growth, FIS holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5M | $151M | $867M | $255M | $10.9B |
| EBITDAEarnings before interest/tax | -$23M | $15M | $241M | $46M | $3.8B |
| Net IncomeAfter-tax profit | -$12M | $11M | $169M | $31M | $382M |
| Free Cash FlowCash after capex | -$10M | $9M | $225M | $30M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +55.8% | +63.5% | +72.1% | +61.7% | +38.1% |
| Operating MarginEBIT ÷ Revenue | -5.2% | +9.1% | +25.3% | +15.7% | +17.5% |
| Net MarginNet income ÷ Revenue | -2.5% | +7.1% | +19.5% | +12.3% | +3.5% |
| FCF MarginFCF ÷ Revenue | -2.1% | +2.5% | +25.2% | +12.5% | +26.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.8% | — | — | — | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +2.6% | +39.5% | +8.3% | +92.3% |
Valuation Metrics
Evenly matched — BRBS and FIS each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 79% valuation discount to FIS's 63.0x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs FIS's 2.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $467M | $320M | $2.4B | $580M | $24.5B |
| Enterprise ValueMkt cap + debt − cash | $274M | $383M | $2.5B | $654M | $27.9B |
| Trailing P/EPrice ÷ TTM EPS | -20.62x | 31.82x | 13.53x | 18.71x | 63.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 10.80x | 4.77x | 7.54x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.92x | — | 2.58x |
| EV / EBITDAEnterprise value multiple | — | 25.54x | 10.35x | 16.34x | 7.66x |
| Price / SalesMarket cap ÷ Revenue | 92.59x | 2.13x | 2.71x | 2.28x | 2.29x |
| Price / BookPrice ÷ Book value/share | 1.21x | 1.15x | 1.21x | 1.40x | 1.76x |
| Price / FCFMarket cap ÷ FCF | — | 85.53x | 10.75x | 18.25x | 9.97x |
Profitability & Efficiency
Evenly matched — RR and FIS each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-4 for RR. RR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBS's 0.55x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs BRBS's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.6% | +3.1% | +9.5% | +7.6% | +2.7% |
| ROA (TTM)Return on assets | -3.5% | +0.4% | +1.1% | +0.7% | +1.1% |
| ROICReturn on invested capital | -25.7% | +2.0% | +7.9% | +5.7% | +6.0% |
| ROCEReturn on capital employed | -11.5% | +0.5% | +2.4% | +1.5% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.00x | 0.55x | 0.17x | 0.43x | 0.29x |
| Net DebtTotal debt minus cash | -$193M | $63M | $142M | $73M | $3.4B |
| Cash & Equiv.Liquid assets | $194M | $116M | $185M | $105M | $599M |
| Total DebtShort + long-term debt | $730,000 | $179M | $327M | $179M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -158.47x | 0.23x | 1.05x | 0.39x | 4.64x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $3,234 for BRBS. Over the past 12 months, CARE leads with a +69.0% total return vs FIS's -35.3%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.9% vs RR's -20.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.0% | -4.4% | +9.3% | +34.8% | -27.3% |
| 1-Year ReturnPast 12 months | +29.5% | +24.6% | +9.0% | +69.0% | -35.3% |
| 3-Year ReturnCumulative with dividends | -49.0% | -43.9% | +54.1% | +94.7% | -6.6% |
| 5-Year ReturnCumulative with dividends | -49.0% | -67.7% | +29.9% | +87.2% | -63.2% |
| 10-Year ReturnCumulative with dividends | -49.0% | -12.5% | +102.2% | +112.9% | -13.2% |
| CAGR (3Y)Annualised 3-year return | -20.1% | -17.5% | +15.5% | +24.9% | -2.2% |
Risk & Volatility
Evenly matched — BRBS and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRBS is the less volatile stock with a 0.54 beta — it tends to amplify market swings less than RR's 4.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs RR's 36.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.02x | 0.54x | 0.89x | 0.56x | 0.76x |
| 52-Week HighHighest price in past year | $7.43 | $4.79 | $46.92 | $26.58 | $82.74 |
| 52-Week LowLowest price in past year | $1.71 | $3.25 | $39.20 | $15.37 | $43.30 |
| % of 52W HighCurrent price vs 52-week peak | +36.1% | +73.1% | +96.1% | +98.5% | +57.1% |
| RSI (14)Momentum oscillator 0–100 | 61.5 | 35.1 | 57.3 | 75.4 | 43.3 |
| Avg Volume (50D)Average daily shares traded | 8.4M | 380K | 236K | 276K | 5.5M |
Analyst Outlook
Evenly matched — BRBS and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RR as "Buy", NBTB as "Hold", CARE as "Buy", FIS as "Buy". Consensus price targets imply 123.9% upside for RR (target: $6) vs 2.1% for NBTB (target: $46). For income investors, BRBS offers the higher dividend yield at 6.08% vs NBTB's 3.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $6.00 | — | $46.00 | $27.00 | $67.38 |
| # AnalystsCovering analysts | 2 | — | 10 | 4 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | +6.1% | +3.2% | — | +3.5% |
| Dividend StreakConsecutive years of raises | — | 0 | 12 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.21 | $1.43 | — | $1.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.0% | +0.4% | +3.4% | 0.0% |
NBTB leads in 1 of 6 categories (Income & Cash Flow). CARE leads in 1 (Total Returns). 4 tied.
RR vs BRBS vs NBTB vs CARE vs FIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RR or BRBS or NBTB or CARE or FIS a better buy right now?
For growth investors, Richtech Robotics Inc.
Class B Common Stock (RR) is the stronger pick with 19. 0% revenue growth year-over-year, versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Richtech Robotics Inc. Class B Common Stock (RR) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RR or BRBS or NBTB or CARE or FIS?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus Fidelity National Information Services, Inc. at 63. 0x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fidelity National Information Services, Inc. wins at 0. 31x versus NBT Bancorp Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RR or BRBS or NBTB or CARE or FIS?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -67. 7% for Blue Ridge Bankshares, Inc. (BRBS). Over 10 years, the gap is even starker: CARE returned +112. 9% versus RR's -49. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RR or BRBS or NBTB or CARE or FIS?
By beta (market sensitivity over 5 years), Blue Ridge Bankshares, Inc.
(BRBS) is the lower-risk stock at 0. 54β versus Richtech Robotics Inc. Class B Common Stock's 4. 02β — meaning RR is approximately 640% more volatile than BRBS relative to the S&P 500. On balance sheet safety, Richtech Robotics Inc. Class B Common Stock (RR) carries a lower debt/equity ratio of 0% versus 55% for Blue Ridge Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RR or BRBS or NBTB or CARE or FIS?
By revenue growth (latest reported year), Richtech Robotics Inc.
Class B Common Stock (RR) is pulling ahead at 19. 0% versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). On earnings-per-share growth, the picture is similar: Blue Ridge Bankshares, Inc. grew EPS 135. 5% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Over a 3-year CAGR, FIS leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RR or BRBS or NBTB or CARE or FIS?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus -312. 3% for Richtech Robotics Inc. Class B Common Stock — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus -355. 7% for RR. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RR or BRBS or NBTB or CARE or FIS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fidelity National Information Services, Inc. (FIS) is the more undervalued stock at a PEG of 0. 31x versus NBT Bancorp Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 10. 8x for NBT Bancorp Inc. — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RR: 123. 9% to $6. 00.
08Which pays a better dividend — RR or BRBS or NBTB or CARE or FIS?
In this comparison, BRBS (6.
1% yield), FIS (3. 5% yield), NBTB (3. 2% yield) pay a dividend. RR, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is RR or BRBS or NBTB or CARE or FIS better for a retirement portfolio?
For long-horizon retirement investors, Blue Ridge Bankshares, Inc.
(BRBS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 54), 6. 1% yield). Richtech Robotics Inc. Class B Common Stock (RR) carries a higher beta of 4. 02 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BRBS: -12. 5%, RR: -49. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RR and BRBS and NBTB and CARE and FIS?
These companies operate in different sectors (RR (Industrials) and BRBS (Financial Services) and NBTB (Financial Services) and CARE (Financial Services) and FIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RR is a small-cap high-growth stock; BRBS is a small-cap income-oriented stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FIS is a mid-cap income-oriented stock. BRBS, NBTB, FIS pay a dividend while RR, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.